Literature DB >> 25774505

Resetting the transcription factor network reverses terminal chronic hepatic failure.

Taichiro Nishikawa, Aaron Bell, Jenna M Brooks, Kentaro Setoyama, Marta Melis, Bing Han, Ken Fukumitsu, Kan Handa, Jianmin Tian, Klaus H Kaestner, Yoram Vodovotz, Joseph Locker, Alejandro Soto-Gutierrez, Ira J Fox.   

Abstract

The cause of organ failure is enigmatic for many degenerative diseases, including end-stage liver disease. Here, using a CCl4-induced rat model of irreversible and fatal hepatic failure, which also exhibits terminal changes in the extracellular matrix, we demonstrated that chronic injury stably reprograms the critical balance of transcription factors and that diseased and dedifferentiated cells can be returned to normal function by re-expression of critical transcription factors, a process similar to the type of reprogramming that induces somatic cells to become pluripotent or to change their cell lineage. Forced re-expression of the transcription factor HNF4α induced expression of the other hepatocyte-expressed transcription factors; restored functionality in terminally diseased hepatocytes isolated from CCl4-treated rats; and rapidly reversed fatal liver failure in CCl4-treated animals by restoring diseased hepatocytes rather than replacing them with new hepatocytes or stem cells. Together, the results of our study indicate that disruption of the transcription factor network and cellular dedifferentiation likely mediate terminal liver failure and suggest reinstatement of this network has therapeutic potential for correcting organ failure without cell replacement.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25774505      PMCID: PMC4396487          DOI: 10.1172/JCI73137

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  EFFECTS OF THE PYRROLIZIDINE ALKALOID, LASIOCARPINE N-OXIDE, ON NUCLEAR AND CELL DIVISION IN THE LIVER RATS.

Authors:  J E PETERSON
Journal:  J Pathol Bacteriol       Date:  1965-01

Review 2.  Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.

Authors:  François Durand; Dominique Valla
Journal:  J Hepatol       Date:  2004-12-24       Impact factor: 25.083

3.  Plasticity and expanding complexity of the hepatic transcription factor network during liver development.

Authors:  Irene Kyrmizi; Pantelis Hatzis; Nitsa Katrakili; Francois Tronche; Frank J Gonzalez; Iannis Talianidis
Journal:  Genes Dev       Date:  2006-08-15       Impact factor: 11.361

4.  Evidence of the intact hepatocyte theory in alcoholic cirrhosis.

Authors:  M Vaubourdolle; V Gufflet; J Guechot; F Ballet; P Jaillon; J Giboudeau; R Poupon
Journal:  Scand J Gastroenterol       Date:  1989-05       Impact factor: 2.423

5.  Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice.

Authors:  S Ponnazhagan; P Mukherjee; M C Yoder; X S Wang; S Z Zhou; J Kaplan; S Wadsworth; A Srivastava
Journal:  Gene       Date:  1997-04-29       Impact factor: 3.688

Review 6.  Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus.

Authors:  Jinah Choi; J-H James Ou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-05       Impact factor: 4.052

7.  Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily.

Authors:  F M Sladek; W M Zhong; E Lai; J E Darnell
Journal:  Genes Dev       Date:  1990-12       Impact factor: 11.361

Review 8.  Update on liver transplantation: indications, organ allocation, and long-term care.

Authors:  Patricia M Lopez; Paul Martin
Journal:  Mt Sinai J Med       Date:  2006-12

Review 9.  Alterations in mitochondrial function and morphology in chronic liver disease: pathogenesis and potential for therapeutic intervention.

Authors:  S Krähenbühl
Journal:  Pharmacol Ther       Date:  1993-10       Impact factor: 12.310

10.  Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine.

Authors:  E Laconi; R Oren; D K Mukhopadhyay; E Hurston; S Laconi; P Pani; M D Dabeva; D A Shafritz
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

View more
  46 in total

Review 1.  Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug.

Authors:  Alexandre J Debacker; Jon Voutila; Matthew Catley; David Blakey; Nagy Habib
Journal:  Mol Ther       Date:  2020-06-17       Impact factor: 11.454

Review 2.  Liver-Regenerative Transplantation: Regrow and Reset.

Authors:  A Collin de l'Hortet; K Takeishi; J Guzman-Lepe; K Handa; K Matsubara; K Fukumitsu; K Dorko; S C Presnell; H Yagi; A Soto-Gutierrez
Journal:  Am J Transplant       Date:  2016-02-18       Impact factor: 8.086

3.  Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha.

Authors:  Seema S Desai; Jason C Tung; Vivian X Zhou; James P Grenert; Yann Malato; Milad Rezvani; Regina Español-Suñer; Holger Willenbring; Valerie M Weaver; Tammy T Chang
Journal:  Hepatology       Date:  2016-03-09       Impact factor: 17.425

Review 4.  Splicing alterations contributing to cancer hallmarks in the liver: central role of dedifferentiation and genome instability.

Authors:  Maddalen Jimenez; María Arechederra; Matías A Ávila; Carmen Berasain
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-31

5.  Differentiation in stem/progenitor cells along fetal or adult hepatic stages requires transcriptional regulators independently of oscillations in microRNA expression.

Authors:  Sriram Bandi; Sanchit Gupta; Tatyana Tchaikovskaya; Sanjeev Gupta
Journal:  Exp Cell Res       Date:  2018-06-06       Impact factor: 3.905

6.  Liver: Reprogramming a hepatocyte's memory of liver disease.

Authors:  Christine Weber
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-31       Impact factor: 46.802

7.  In vivo reprogramming of hepatic myofibroblasts into hepatocytes attenuates liver fibrosis: back to the future?

Authors:  Erica Novo; Stefania Cannito; Maurizio Parola
Journal:  Stem Cell Investig       Date:  2016-09-29

Review 8.  Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells.

Authors:  Chen Chen; Alejandro Soto-Gutierrez; Pedro M Baptista; Bart Spee
Journal:  Gastroenterology       Date:  2018-02-08       Impact factor: 22.682

9.  Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis.

Authors:  Zhongwei Cao; Tinghong Ye; Yue Sun; Gaili Ji; Koji Shido; Yutian Chen; Lin Luo; Feifei Na; Xiaoyan Li; Zhen Huang; Jane L Ko; Vivek Mittal; Lina Qiao; Chong Chen; Fernando J Martinez; Shahin Rafii; Bi-Sen Ding
Journal:  Sci Transl Med       Date:  2017-08-30       Impact factor: 17.956

10.  Hedgehog regulates yes-associated protein 1 in regenerating mouse liver.

Authors:  Marzena Swiderska-Syn; Guanhua Xie; Gregory A Michelotti; Mark L Jewell; Richard T Premont; Wing-Kin Syn; Anna Mae Diehl
Journal:  Hepatology       Date:  2016-04-21       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.